US EditionTecovirimat monotherapy found ineffective for treating clade II mpox in NIH-sponsored trial
- More than 600 people infected with Mpox fled treatment centers in the Democratic Republic of Congo due to fighting, according to the Africa Centers for Disease Control.
- Although over 150 of those who escaped returned, many remain unaccounted for due to ongoing conflict in the region.
- The M23 rebel group has hindered efforts to contain Mpox, affecting hospitals and medical supplies, reported Dr. Cikuru.
- Authorities have started negotiations for a humanitarian corridor to allow aid access amid the conflict, as per Africa CDC's Mpox Incident Manager Dr. Ngashi Ngongo.
18 Articles
18 Articles
Congo-Kinshasa: DR Congo Fighting Forces Hundreds of Mpox Patients to Leave Treatment Centres
Monrovia -- More than 600 people infected with mpox left treatment centers in the Democratic Republic of Congo due to fighting in the eastern part of the country, the African Centers for Disease Control said during an online briefing on the status of the disease on March 6. The continental health body said, although more than 150 of those who ran away returned in the eastern city of Bukavu - following a relative improvement in security - they st…
Health ministry records 27 suspected Mpox cases in Juba
Central Equatoria has recorded 27 suspected Mpox cases following the confirmation of six cases since the outbreak was detected in Juba last month, according to the state health minister’s briefing during a cabinet meeting on Thursday. The first index case which prompted declaration of the outbreak was confirmed on February 7, in a 31-year-old man, a Ugandan national who works with a company in Juba. CES Acting Minister of Information, Jacob Alig…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
